JTBR
BBIO icon

James T. Borello RIA’s BridgeBio Pharma BBIO Stock Holding History

James T. Borello RIA’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$855 Sell
13
-1
-7% -$78 ﹤0.01% 1003
2026
Q2 		$1.04K Hold
14
– – ﹤0.01% 1015
2026
Q1 		$1.04K Buy
14
+4
+40% +$290 ﹤0.01% 1008
2025
Q4 		$765 Hold
10
– – ﹤0.01% 896
2025
Q3 		$519 Buy
+10
New +$488 ﹤0.01% 871

Other funds holding BBIO

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

James T. Borello RIA's BBIO Position: Q3 2026 in Review

James T. Borello RIA reduced its BridgeBio Pharma (BBIO) stake by 7.1% in Q3 2026, selling an estimated $78 and leaving 13 shares worth $855. The position accounts for ﹤0.01% of the portfolio, ranked #1003.

James T. Borello RIA first reported a position in BBIO in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.04K in Q2 2026. 38 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • James T. Borello RIA held 13 shares of BridgeBio Pharma worth $855 as of Q3 2026.
  • James T. Borello RIA sold 1 BridgeBio Pharma share in Q3 2026, an estimated $78.
  • BridgeBio Pharma made up ﹤0.01% of James T. Borello RIA's portfolio in Q3 2026, its #1003 holding.
  • James T. Borello RIA first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 5 quarters since.
  • James T. Borello RIA's BridgeBio Pharma position peaked at $1.04K in Q2 2026.
  • 38 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.